Co-pay & financial assistance for eligible patients
BMS Access Support® can help identify financial assistance programs for eligible patients who have been prescribed BMS medications and who need help managing the cost of treatment. The appropriate program will depend on the patient’s coverage. Explore the tabs below for more information about how we may support your patient’s journey.
Patients With Commercial Insurance
The BMS Access Support Co-Pay Assistance Program helps eligible, commercially insured patients who have been prescribed select BMS medications with out-of-pocket deductibles, co-pays, or co-insurance requirements.
Co-pay Program Portal Directory
Visit the co-pay program portal directory to manage your patient's co-pay claims.
BMS Access Support Co-Pay Assistance Program
For Select HCP-Administered Medications
$0 Co-pay* per dose
Subject to a maximum benefit
Restrictions apply. For additional information about eligibility and product-specific annual maximum benefit, please view the Terms and Conditions below.
If a patient was prescribed:
ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
EMPLICITI® (elotuzumab)
OPDIVO® (nivolumab) and OPDIVO Combination
OPDIVO QVANTIG™ (nivolumab and hyaluronidase-nvhy)
OPDUALAG™ (nivolumab and relatlimab-rmbw)
REBLOZYL® (luspatercept-aamt)
YERVOY® (ipilimumab)
*Note: If you would like to utilize electronic funds transfer (EFT), please contact your Access and Reimbursement Manager.
For Select Oral Medications
$0 Co-pay per one-month supply
Subject to a maximum benefit
Restrictions apply. For additional information about eligibility and product-specific annual maximum benefit, please view the Terms and Conditions below.
If a patient was prescribed:
AUGTYRO™ (repotrectinib)
IDHIFA® (enasidenib)
INREBIC® (fedratinib)
KRAZATI® (adagrasib)
ONUREG® (azacitidine)
POMALYST® (pomalidomide)
REVLIMID® (lenalidomide)
SPRYCEL® (dasatinib)
THALOMID® (thalidomide)
If a patient was prescribed: NULOJIX® (belatacept)
Enroll eligible patients in services.
U.S. Full Prescribing Information for ABRAXANE, including Boxed WARNING
U.S. Full Prescribing Information for IDHIFA, including Boxed WARNING
U.S. Full Prescribing Information for INREBIC, including Boxed WARNING
U.S. Full Prescribing Information for NULOJIX, including Boxed WARNINGS
U.S. Full Prescribing Information for POMALYST, including Boxed WARNINGS
U.S. Full Prescribing Information for REVLIMID, including Boxed WARNINGS
U.S. Full Prescribing Information for THALOMID, including Boxed WARNINGS
Patients With Government Insurance
- Patients insured through government healthcare programs, such as Medicare, Medicaid, and TRICARE, are not eligible for co-pay assistance programs sponsored by Bristol Myers Squibb. However, BMS Access Support may be able to provide information about independent charitable foundations that may be able to provide financial support.
- It is important to note that these charitable foundations are independent from Bristol-Myers Squibb Company. Each foundation has its own eligibility criteria and evaluation process. Bristol Myers Squibb cannot guarantee that a patient will receive assistance.
- For more information, call BMS Access Support at 1-800-861-0048 to speak with a Patient Access Specialist.
Patients Without Prescription Drug Coverage or Who Are Underinsured
- For patients without prescription drug insurance or for patients who are underinsured, BMS Access Support can provide information about independent charitable foundations that may be able to help.
- It is important to note that charitable foundations are independent from Bristol-Myers Squibb Company. Each foundation has its own eligibility criteria and evaluation process. Bristol Myers Squibb cannot guarantee that a patient will receive assistance. For more information, call BMS Access Support at 1-800-861-0048 to speak with a Patient Access Specialist.
HCP Reimbursement Process Map
What is Health Insurance?
